NO20044633L - Nye alkoksypyridinderivater - Google Patents

Nye alkoksypyridinderivater

Info

Publication number: NO20044633L
Authority: NO; Norway
Prior art keywords: new; alkoxypyridine; derivatives; alkoxypyridine derivatives; purin
Prior art date: 2002-03-27

Application number

NO20044633A

Other languages

English (en)

Norwegian (no)

Inventor

Manfrid Eltze

Ruediger Nave

Wolf-Ruediger Ulrich

Johannes Barsig

Rainer Boer

Degenhard Marx

Thomas Klein

Ulrich Gradler

Thomas Fuchss

Original Assignee

Altana Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-27

Filing date

2004-10-27

Publication date

2004-12-23

2004-10-27 Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag

2004-12-23 Publication of NO20044633L publication Critical patent/NO20044633L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Dermatology (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Transplantation (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Pulmonology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyridine Compounds (AREA)

NO20044633A 2002-03-27 2004-10-27 Nye alkoksypyridinderivater NO20044633L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP02007049		2002-03-27
PCT/EP2003/003076 WO2003080607A1 (en)	2002-03-27	2003-03-25	Novel alkoxypyridine-derivatives

Publications (1)

Publication Number	Publication Date
NO20044633L true NO20044633L (no)	2004-12-23

Family

ID=28051741

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20044633A NO20044633L (no)	2002-03-27	2004-10-27	Nye alkoksypyridinderivater

Country Status (19)

Country	Link
US (1)	US7138399B2 (de)
EP (1)	EP1490366B1 (de)
JP (1)	JP4448695B2 (de)
KR (1)	KR20050002910A (de)
CN (1)	CN1307176C (de)
AT (1)	ATE384722T1 (de)
AU (1)	AU2003226706A1 (de)
BR (1)	BR0308785A (de)
CA (1)	CA2480385A1 (de)
DE (1)	DE60318826T2 (de)
ES (1)	ES2300599T3 (de)
HK (1)	HK1078850A1 (de)
IL (1)	IL163625A0 (de)
MX (1)	MXPA04009283A (de)
NO (1)	NO20044633L (de)
NZ (1)	NZ535959A (de)
PL (1)	PL372409A1 (de)
WO (1)	WO2003080607A1 (de)
ZA (1)	ZA200407766B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2004303515A1 (en) *	2003-10-01	2005-07-07	Altana Pharma Ag	Aminopyridine-derivatives as inductible no-synthase inhibitors
CA2540239A1 (en) *	2003-10-01	2005-04-07	Altana Pharma Ag	Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors
CA2540243A1 (en) *	2003-10-01	2005-04-07	Altana Pharma Ag	Imidazopyridine-derivatives as inducible no-synthase inhibitors
EP1673371B1 (de) *	2003-10-01	2008-08-06	Nycomed GmbH	Imidazopyridinderivate als induzierbare no-synthaseinhibitoren
RS20060196A (en) *	2003-10-01	2008-08-07	Altana Pharma Ag.,	Imidazopyridine-derivatives as inducible no-synthase inhibitors
WO2005063732A1 (en) *	2003-12-23	2005-07-14	Microbia, Inc.	Compounds and methods for the treatment of asthma
US7723523B2 (en)	2004-05-28	2010-05-25	4Sc Ag	Tetrahydropyridothiophenes
AU2005251485A1 (en)	2004-06-11	2005-12-22	4Sc Ag	Tetrahydropyridothiophenes for treating hyperproliferative disorders
JP2008529989A (ja)	2005-02-09	2008-08-07	ニコメッドゲゼルシャフトミットベシュレンクテルハフツング	癌のような増殖性の疾病の治療用のテトラヒドロピリドチオフェン
JP2008530053A (ja)	2005-02-11	2008-08-07	ニコメッドゲゼルシャフトミットベシュレンクテルハフツング	癌の治療のための抗増殖性剤としてのテトラヒドロピリドチオフェン
CA2602284A1 (en) *	2005-03-31	2006-10-05	Nycomed Gmbh	Imidazopyridine derivatives useful as inos inhibitors
WO2006125813A2 (en)	2005-05-25	2006-11-30	Nycomed Gmbh	Tetrahydropyridothiophenes for use in the treatment of cancer
AU2006251169A1 (en)	2005-05-25	2006-11-30	4Sc Ag	Tetrahydropyridothiophenes for use in the treatment of cancer
UY29823A1 (es) *	2005-10-03	2007-05-31	Astrazeneca Ab	Derivados sustituidos de 7-cloro-3h-imidazol-(4,5-b) piridina, composiciones farmacéuticas que los contienen, procesos para la preparación de los mismos y aplicaciones
AR055669A1 (es) *	2005-10-03	2007-08-29	Astrazeneca Ab	Derivados de 3h - imidazo[4, 5 -b]piridina como inhibidores selectivos de gsk3, metodos e internediarios para su preparacion, composiciones farmaceuticas que los contienen y su uso para la elaboracion de un medicamento para el tratamiento de enfermedades neurodegenerativas y mentales.
WO2008031788A1 (en) *	2006-09-12	2008-03-20	Nycomed Gmbh	Aminoazepine derivatives as highly efficient inhibitors of the inducible nitric oxide synthase
US20080139608A1 (en) *	2006-12-06	2008-06-12	Universiteit Leiden	2,6,8, Trisubstituted 1-deazapurines and their different uses
EA025380B1 (ru) *	2011-02-25	2016-12-30	Мерк Шарп Энд Домэ Корп.	Новые циклические производные азабензимидазола, используемые в качестве антидиабетических агентов
RU2014105650A (ru)	2011-07-15	2015-08-27	Сионоги Энд Ко., Лтд.	Производное азабензимидазола, обладающее амрк-активирующей активностью
GB201512635D0 (en)	2015-07-17	2015-08-26	Ucl Business Plc	Uses of therapeutic compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE418966B (sv)	1974-02-18	1981-07-06	Haessle Ab	Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
GB8307865D0 (en) *	1983-03-22	1983-04-27	Fujisawa Pharmaceutical Co	Benzimidazole derivatives
GB8515934D0 (en)	1985-06-24	1985-07-24	Janssen Pharmaceutica Nv	(4-piperidinomethyl and-hetero)purines
SE512835C2 (sv) *	1996-01-08	2000-05-22	Astrazeneca Ab	Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare

2003
- 2003-03-25 US US10/509,396 patent/US7138399B2/en not_active Expired - Fee Related
- 2003-03-25 JP JP2003578361A patent/JP4448695B2/ja not_active Expired - Fee Related
- 2003-03-25 AT AT03744851T patent/ATE384722T1/de not_active IP Right Cessation
- 2003-03-25 EP EP03744851A patent/EP1490366B1/de not_active Expired - Lifetime
- 2003-03-25 DE DE60318826T patent/DE60318826T2/de not_active Expired - Lifetime
- 2003-03-25 WO PCT/EP2003/003076 patent/WO2003080607A1/en active IP Right Grant
- 2003-03-25 BR BR0308785-9A patent/BR0308785A/pt not_active IP Right Cessation
- 2003-03-25 CA CA002480385A patent/CA2480385A1/en not_active Abandoned
- 2003-03-25 MX MXPA04009283A patent/MXPA04009283A/es active IP Right Grant
- 2003-03-25 PL PL03372409A patent/PL372409A1/xx not_active Application Discontinuation
- 2003-03-25 KR KR10-2004-7015438A patent/KR20050002910A/ko not_active Application Discontinuation
- 2003-03-25 NZ NZ535959A patent/NZ535959A/en not_active IP Right Cessation
- 2003-03-25 CN CNB038069172A patent/CN1307176C/zh not_active Expired - Fee Related
- 2003-03-25 ES ES03744851T patent/ES2300599T3/es not_active Expired - Lifetime
- 2003-03-25 IL IL16362503A patent/IL163625A0/xx unknown
- 2003-03-25 AU AU2003226706A patent/AU2003226706A1/en not_active Abandoned
2004
- 2004-09-27 ZA ZA200407766A patent/ZA200407766B/en unknown
- 2004-10-27 NO NO20044633A patent/NO20044633L/no not_active Application Discontinuation
2005
- 2005-11-23 HK HK05110611A patent/HK1078850A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
NZ535959A (en)	2006-05-26
US7138399B2 (en)	2006-11-21
ATE384722T1 (de)	2008-02-15
WO2003080607A1 (en)	2003-10-02
MXPA04009283A (es)	2005-01-25
BR0308785A (pt)	2005-01-11
JP2005525388A (ja)	2005-08-25
KR20050002910A (ko)	2005-01-10
ES2300599T3 (es)	2008-06-16
DE60318826D1 (de)	2008-03-13
CA2480385A1 (en)	2003-10-02
DE60318826T2 (de)	2009-01-22
PL372409A1 (en)	2005-07-25
EP1490366B1 (de)	2008-01-23
US20050171125A1 (en)	2005-08-04
IL163625A0 (en)	2005-12-18
JP4448695B2 (ja)	2010-04-14
EP1490366A1 (de)	2004-12-29
ZA200407766B (en)	2006-06-28
CN1642955A (zh)	2005-07-20
HK1078850A1 (en)	2006-03-24
CN1307176C (zh)	2007-03-28
AU2003226706A1 (en)	2003-10-08

Publication	Publication Date	Title
NO20044633L (no)	2004-12-23	Nye alkoksypyridinderivater
NO20060670L (no)	2006-05-12	N3-substituerte imidazopyridin C-kit inhibitorer
NO20044731L (no)	2004-12-30	Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere
NO20060664L (no)	2006-05-16	N-substituerte benzimidazolyl C-kit inhibitorer
AU2002246728A1 (en)	2002-08-28	Carboline derivatives
NO20043176L (no)	2004-07-26	Nikotinamidderivater nyttige som P38 inhibitorer
EA200400305A1 (ru)	2004-08-26	2,4,5-тризамещенные производные тиазолила и их противовоспалительная активность
NO20063132L (no)	2006-09-11	Naftyridinderivater og deres anvendelse som modulatorer av muskarinreceptorer
BR0014352A (pt)	2002-06-11	Cetoenóis espirocìclicos substituìdos por trifluormetila
ATE226208T1 (de)	2002-11-15	4-oxo-4,7-dihydro-thieno(2,3-b)pyridin-5- carboxamide als antivirale mittel
NO20060665L (no)	2006-05-16	N-substituerte pyrazolyl-amidyl-benzimidazolyl C-kit inhibitorer
WO2003013484A3 (en)	2003-04-17	N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
NO992492L (no)	1999-05-25	Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer
ATE346067T1 (de)	2006-12-15	Carbolinderivate
NO20061317L (no)	2006-03-23	Imidazopyridinderivater som induserbare NO-syntaseinhibatorer
NO20051051L (no)	2005-03-29	Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme i terapeutiske midler
NO20061789L (no)	2006-04-24	Aminopyridinderivater som induserbare NO-syntaseinhibitorer
NO20031722D0 (no)	2003-04-14	Nye 7-azaindoler, anvendelse av de samme som fosfodiesterase- 4-inhibitorerog fremgangsmåte for fremstilling av de samme
WO2003045901A3 (en)	2003-07-31	Guanidine derivatives
NO20054476L (no)	2005-11-24	Forbindelser for behandling av smerte
NO20013384L (no)	2001-07-06	Imidazo[4,5-c]pyridin-4-on-derivater
NO20063220L (no)	2006-07-11	Tricykliske imidazopyridiner for anvendelse som gastriske sekresjonsinhibitorer
DK454086D0 (da)	1986-09-23	Quinolinderivater og deres anvendelse
NO814113L (no)	1982-06-07	2-oksoazetidinderivater og fremgangsmaate for deres fremstilling
DK513384D0 (da)	1984-10-26	Griseolsyrederivater og deres anvendelse

Legal Events

Date	Code	Title	Description
2008-04-28	CREP	Change of representative	Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104
2009-10-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application